These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 37543978)
1. Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in colorectal cancer. Li Y; Tang M; Dang W; Zhu S; Wang Y J Cancer Res Clin Oncol; 2023 Nov; 149(15):13995-14014. PubMed ID: 37543978 [TBL] [Abstract][Full Text] [Related]
2. Role of disulfidptosis in colorectal adenocarcinoma: implications for prognosis and immunity. Yang R; Lai C; Huang L; Li F; Peng W; Wu M; Xin J; Lu Y; Ouyang M; Bai Y; Lei H; He S; Lin Y Front Immunol; 2024; 15():1409149. PubMed ID: 39399504 [TBL] [Abstract][Full Text] [Related]
3. Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which Xu K; Zhang Y; Yan Z; Wang Y; Li Y; Qiu Q; Du Y; Chen Z; Liu X Front Immunol; 2023; 14():1205250. PubMed ID: 37426643 [TBL] [Abstract][Full Text] [Related]
4. A novel disulfidptosis-associated expression pattern in breast cancer based on machine learning. Wang Z; Du X; Lian W; Chen J; Hong C; Li L; Chen D Front Genet; 2023; 14():1193944. PubMed ID: 37456667 [No Abstract] [Full Text] [Related]
5. Investigating the prognostic value of constructing disulfidptosis-related gene models for lung adenocarcinoma patients. Luo M; Liu RZ; Li YJ; Zhang SD; Wu ZY Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9569-9585. PubMed ID: 37916324 [TBL] [Abstract][Full Text] [Related]
6. Creation of signatures and identification of molecular subtypes of glioblastoma based on disulfidptosis-related genes for predicting patient prognosis and immunological activity. Li D; Li X; Lv J; Li S Asian J Surg; 2024 Aug; 47(8):3464-3477. PubMed ID: 38462406 [TBL] [Abstract][Full Text] [Related]
7. The role of molecular subtypes and immune infiltration characteristics based on disulfidptosis-associated genes in lung adenocarcinoma. Qi C; Ma J; Sun J; Wu X; Ding J Aging (Albany NY); 2023 Jun; 15(11):5075-5095. PubMed ID: 37315289 [TBL] [Abstract][Full Text] [Related]
8. Identification of disulfidptosis-related subtypes and development of a prognosis model based on stacking framework in renal clear cell carcinoma. Peng K; Wang N; Liu Q; Wang L; Duan X; Xie G; Li J; Ding D J Cancer Res Clin Oncol; 2023 Nov; 149(15):13793-13810. PubMed ID: 37530800 [TBL] [Abstract][Full Text] [Related]
9. Identifying disulfidptosis subtypes in hepatocellular carcinoma through machine learning and preliminary exploration of its connection with immunotherapy. Chen G; Zhang G; Zhu Y; Wu A; Fang J; Yin Z; Chen H; Cao K Cancer Cell Int; 2024 Jun; 24(1):194. PubMed ID: 38831301 [TBL] [Abstract][Full Text] [Related]
10. Identification of Key Disulfidptosis-Related Genes and Their Association with Gene Expression Subtypes in Crohn's Disease. Fu M; Aihemaiti D; Fu H; Li N; Yuan Y; Ye M J Inflamm Res; 2024; 17():3655-3670. PubMed ID: 38863903 [TBL] [Abstract][Full Text] [Related]
11. Identification and validation of disulfidptosis-related gene signatures and their subtype in diabetic nephropathy. Xu D; Jiang C; Xiao Y; Ding H Front Genet; 2023; 14():1287613. PubMed ID: 38028597 [No Abstract] [Full Text] [Related]
12. Disulfidptosis signature predicts immune microenvironment and prognosis of gastric cancer. Liu Z; Sun L; Zhu W; Zhu J; Wu C; Peng X; Tian H; Huang C; Zhu Z Biol Direct; 2024 Aug; 19(1):65. PubMed ID: 39148138 [TBL] [Abstract][Full Text] [Related]
13. Typing and modeling of hepatocellular carcinoma based on disulfidptosis-related amino acid metabolism genes for predicting prognosis and guiding individualized treatment. Chen X; Wang Z; Wu Y; Lan Y; Li Y Front Oncol; 2023; 13():1204335. PubMed ID: 37637055 [TBL] [Abstract][Full Text] [Related]
14. Molecular subtypes of disulfidptosis-regulated genes and prognosis models for predicting prognosis, tumor microenvironment infiltration, and therapeutic response in hepatocellular carcinoma. Qu J; Guan H; Zheng Q; Sun F Int J Biol Macromol; 2024 Mar; 261(Pt 1):129584. PubMed ID: 38246443 [TBL] [Abstract][Full Text] [Related]
15. Exploring the role of disulfidptosis-related signatures in immune microenvironment, prognosis and therapeutic strategies of cervical cancer. Jin T; Yin T; Xu R; Liu H; Yuan S; Xue Y; Zhang J; Wang H Transl Oncol; 2024 Jun; 44():101938. PubMed ID: 38492499 [TBL] [Abstract][Full Text] [Related]
16. A novel prognostic signature and immune microenvironment characteristics associated with disulfidptosis in papillary thyroid carcinoma based on single-cell RNA sequencing. Liao Z; Cheng Y; Zhang H; Jin X; Sun H; Wang Y; Yan J Front Cell Dev Biol; 2023; 11():1308352. PubMed ID: 38033866 [No Abstract] [Full Text] [Related]
17. Classification and functional analysis of disulfidptosis-associated genes in sepsis. He S; Zhang X; Wang Z; Zhang Q; Yao Y; Pang J; Chen Y J Cell Mol Med; 2024 Oct; 28(19):e70020. PubMed ID: 39400961 [TBL] [Abstract][Full Text] [Related]
18. Identification and validation of disulfidptosis-associated molecular clusters in non-alcoholic fatty liver disease. Yu X; Guo Z; Fang Z; Yang K; Liu C; Dong Z; Liu C Front Genet; 2023; 14():1251999. PubMed ID: 37745847 [No Abstract] [Full Text] [Related]
19. A bioinformatics approach to identify a disulfidptosis-related gene signature for prognostic implication in colon adenocarcinoma. Hu G; Yao H; Wei Z; Li L; Yu Z; Li J; Luo X; Guo Z Sci Rep; 2023 Jul; 13(1):12403. PubMed ID: 37524774 [TBL] [Abstract][Full Text] [Related]
20. Disulfidptosis-related signature predicts prognosis and characterizes the immune microenvironment in hepatocellular carcinoma. Tang J; Peng X; Xiao D; Liu S; Tao Y; Shu L Cancer Cell Int; 2024 Jan; 24(1):19. PubMed ID: 38195525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]